Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Gastrointestinal Microbiome: early-phase trial registry

6 of 7 indexed Gastrointestinal Microbiome trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Gastrointestinal Microbiome: 7 US clinical trials tracked, 6 recruiting.

Gastrointestinal Microbiome is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is ProgenaBiome, running 1 of these trials.

Enrollment posture brief

Registry condition gastrointestinal-microbiome

OPEN 6 | RECR 86% | LATE 0 | EARLY 3 | RANK #2497 | SPON 1

Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)

Gastrointestinal Microbi (th…86%ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Gastrointestinal Microbiome

Gastrointestinal Microbiome lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gastrointestinal Microbiome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gastrointestinal Microbiome is recruiting above its size-band peers.

    6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Gastrointestinal Microbiome trials is spread across many organizations.

    ProgenaBiome accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Gastrointestinal Microbiome enrolment sits around 80 participants.

    Median target enrolment is 80 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Gastrointestinal Microbiome research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13

Phase Distribution

PhaseTrial count
Phase 1 3

Named interventions

Most-linked intervention names on Gastrointestinal Microbiome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Controlled, high fat/low fiber diet background diet, sequentially supplemented with an escalating dose of a fiber-blend snack food. Other
1 trials
No Vaginal Seeding Other
1 trials
There is no intervention in this study Other
1 trials
AG1 - Nutritional Supplement Dietary supplement
1 trials
High Cysteine Diet Other
1 trials
Low Cysteine Diet Other
1 trials
Vaginal Seeding Biological
1 trials
Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule. Drug
1 trials

US sites by state

Facility locations filed on Gastrointestinal Microbiome trials. A trial with sites in several states counts in each.

Colorado 2 trials
California 2 trials
Virginia 1 trials
New Jersey 1 trials
Missouri 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gastrointestinal Microbiome page

7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 6 Gastrointestinal Microbiome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • ProgenaBiome sponsors the most Gastrointestinal Microbiome trials on record, review their full trial history before evaluating a specific study. See ProgenaBiome's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastrointestinal Microbiome condition card totals 7 registered trials; most-linked intervention Controlled, high fat/low fiber diet background diet, sequentially supplemented with an escalating dose of a fiber-blend snack food.; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.